Absolute eosinophil count is a reliable prognostic marker in patients with liver cirrhosis: a cross-sectional study at rural central India

Author:

Kumar SunilORCID,Shah Param,Acharya Sourya,Wanjari Anil,Bawankule Shilpa,Agrawal Sachin,Bagga Charan,Talwar Dhruv,Patel Mansi

Abstract

Abstract Background Various laboratory parameters like C-reactive protein (CRP), Cortisol, and Von Willebrand factor antigen have been evaluated independently in foreseeing outcomes of cirrhotic patients. As these parameters lack cost-effectiveness in a rural setup, there is a need for a cost effective and feasible prognostic marker for cirrhotic patients. The present study was aimed at evaluating the role of Absolute Eosinophil Count (AEC) as a prognostic marker in cirrhotic patients. Methods This cross-sectional study was conducted at a rural tertiary care teaching hospital in central India from August 2019 to September 2021. AEC was measured from counter report as a part of automated complete blood counts. Child-Turcotte-Pugh (CTP) score and Model for end stage liver disease (MELD) score were calculated at the time of admission. AEC levels on admission were correlated with mortality and with CTP score and MELD score. Results A total of 110 patients were enrolled with mean age of 46.37 ± 11.6 years. AEC was the significant predictor of mortality at cut off point of ≤ 120 with 80.30% (AUC 0.803; 95% CI: 0.716 to 0.873). AEC was the significant predictor of CTP score ≥ 11 at cut off point of ≤ 148 (AUC 0.726; 95% CI: 0.633 to 0.807). AEC was the significant predictor of MELD score ≥ 25 at cut off point of ≤ 136 (AUC 0.74; 95% CI: 0.647 to 0.819). Significant negative correlation was seen between AEC with Child–Pugh score and MELD score with correlation coefficient of -0.257 and -0.258. Conclusion Low level of AEC on admission fairly predicted raised CTP score and MELD score on admission. Low AEC levels predicted increased mortality in cirrhotic patients making it a cheap and reliable prognostic marker in a rural setup.

Publisher

Springer Science and Business Media LLC

Subject

Hepatology

Reference16 articles.

1. Schuppan D, Afdhal NH (2008) Liver cirrhosis. Lancet 371:838–851.

2. Snyder N, Gajula L, Xiao SY et al (2006) APRI: an easy and validated predictor of hepatic fibrosis in chronic hepatitis C. J ClinGastroenterol 40:535–542.

3. Scaglione S, Kliethermes S, Cao G, Shoham D, Durazo R, Luke A, Volk ML (2015) The epidemiology of cirrhosis in the United States: a population-based study. J ClinGastroenterol 49(8):690–696.

4. Sebastiani G, Castera L, Halfon P, Pol S, Mangia A, Di Marco V et al (2011) The impact of liver disease aetiology and the stages of hepatic fibrosis on the performance of non-invasive fibrosis biomarkers: an international study of 2411 cases. Aliment Pharmacol Ther. 34:1202–1216. https://doi.org/10.1111/j.1365-2036.2011.04861.x.

5. Zhao Y, Ren M, Lu G, Lu X, Yin Y, Zhang D et al (2020) The prognosis analysis of liver cirrhosis with acute variceal bleeding and validation of current prognostic models: a large-scale retrospective cohort study. BioMed Res Int 2020:7372868.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3